Guarantees_NNS and_CC Other_JJ Financial_NNP Commitments_NNP Capital_NNP commitments_NNS At_IN the_DT end_NN of_IN the_DT year_NN ,_, capital_NN commitments_NNS were_VBD :_: Group_NNP Company_NNP 2003 2002 2003 2002_CD 000s_CD 000s_NNS 000s_CD 000s_CD Contracted_VBN but_CC not_RB provided_VBN for_IN 312_CD 308_CD Lease_NNP commitments_NNS Annual_JJ commitments_NNS under_IN non-cancellable_JJ operating_NN leases_NNS are_VBP as_IN follows_VBZ :_: 2003_CD 2002_CD Land_NNP and_CC Land_NNP and_CC buildings_NNS Other_JJ buildings_NNS Other_JJ 000s_CD 000s_CD 000s_NNS 000s_CD GROUP_NNP Expiry_NNP date_NN Within_IN one_CD year_NN 396 293 256 382_CD Between_IN 2-5_CD years_NNS 1,202_CD 630 643 826_CD Over_IN 5_CD years_NNS 1,712_CD 10_CD 1,799_CD 3,310_CD 933_CD 2,698_CD 1,208_CD COMPANY_NNP Expiry_NNP date_NN Over_IN 5_CD years_NNS 802_CD 802_CD Guarantees_NNPS Guarantees_NNPS of_IN nil_NN 2002_CD 300,000_CD have_VBP been_VBN given_VBN by_IN a_DT wholly-owned_JJ subsidiary_NN of_IN the_DT Company_NN in_IN respect_NN of_IN credit_NN facilities_NNS with_IN HM_NNP Customs_NNP &_CC Excise_NNP ._.
Psion_NNP PLC_NNP and_CC its_PRP$ UK_NNP subsidiaries_NNS have_VBP unlimited_JJ composite_JJ guarantees_NNS with_IN their_PRP$ lending_NN banks_NNS to_TO secure_VB banking_NN facilities_NNS for_IN the_DT Group_NNP ._.
Contingent_JJ Liabilities_NNS From_IN time_NN to_TO time_VB the_DT Group_NNP is_VBZ exposed_VBN to_TO claims_NNS of_IN alleged_JJ infringement_NN of_IN patents_NNS which_WDT the_DT group_NN vigorously_RB defends_VBZ ._.
Provision_NNP for_IN costs_NNS is_VBZ made_VBN when_WRB claims_NNS are_VBP indicated_VBN and_CC disclosure_NN is_VBZ made_VBN of_IN potentially_RB material_JJ matters_NNS where_WRB on_IN the_DT basis_NN of_IN legal_JJ advice_NN an_DT adverse_JJ outcome_NN can_MD not_RB currently_RB be_VB judged_VBN as_IN remote_JJ ._.
Lemelson_NNP Medical_NNP ,_, Educational_NNP &_CC Research_NNP Foundation_NNP ,_, L._NNP P._NNP In_IN July_NNP 1999_CD ,_, Psion_NNP Teklogix_NNP and_CC other_JJ leading_VBG members_NNS of_IN the_DT automatic_JJ identification_NN and_CC data_NN capture_NN industry_NN initiated_VBD a_DT joint_JJ legal_JJ action_NN against_IN Lemelson_NNP Medical_NNP ,_, Educational_NNP &_CC Research_NNP Foundation_NNP ,_, L._NNP P._NNP in_IN the_DT state_NN of_IN Nevada_NNP ,_, USA_NNP ,_, claiming_VBG a_DT declaratory_JJ judgement_NN of_IN the_DT court_NN that_WDT intellectual_JJ property_NN rights_NNS asserted_VBD against_IN certain_JJ customers_NNS of_IN Psion_NNP Teklogix_NNP and_CC the_DT Industry_NN Members_NNS by_IN Lemelson_NNP Medical_NNP were_VBD invalid_JJ ,_, unenforcable_JJ and_CC were_VBD not_RB infringed_VBN by_IN the_DT products_NNS of_IN Psion_NNP Teklogix_NNP or_CC the_DT Industry_NN Members_NNS ,_, or_CC by_IN their_PRP$ customers_NNS use_VBP of_IN such_JJ products_NNS ._.
During_IN 2001_CD and_CC 2002_CD ,_, Lemelson_NNP Medical_NNP instigated_VBD legal_JJ action_NN against_IN over_IN 500_CD industrial_JJ companies_NNS in_IN the_DT United_NNP States_NNPS ,_, alleging_VBG that_IN their_PRP$ use_NN of_IN Auto_NN ID_NNP methods_NNS infringed_VBD Lemelson_NNP Medicals_NNP intellectual_JJ property_NN rights_NNS ._.
Some_DT of_IN the_DT companies_NNS against_IN whom_WP Lemelson_NNP Medical_NNP brought_VBD such_PDT an_DT action_NN were_VBD customers_NNS of_IN Psion_NNP Teklogix_NNP ._.
On_IN 23_CD January_NNP 2004_CD ,_, the_DT United_NNP States_NNPS District_NNP Court_NNP of_IN Nevada_NNP found_VBD in_IN favor_NN of_IN Psion_NNP Teklogix_NNP and_CC the_DT Industry_NN Members_NNS ,_, ruling_VBG that_IN the_DT intellectual_JJ property_NN rights_NNS asserted_VBD by_IN Lemelson_NNP Medical_NNP were_VBD invalid_JJ and_CC unenforcable_JJ and_CC were_VBD not_RB infringed_VBN by_IN Psion_NNP Teklogix_NNP or_CC the_DT Industry_NN Members_NNS ._.
Lemelson_NNP Medical_NNP has_VBZ the_DT right_NN to_TO appeal_VB against_IN this_DT judgement_NN ._.
It_PRP is_VBZ not_RB possible_JJ to_TO establish_VB the_DT quantum_NN of_IN Lemelson_NNP Medicals_NNP claim_NN in_IN the_DT event_NN that_IN it_PRP successfully_RB appeals_NNS against_IN the_DT judgement_NN ._.
In_IN light_NN of_IN the_DT judgement_NN and_CC having_VBG taken_VBN legal_JJ advice_NN ,_, the_DT Board_NNP is_VBZ of_IN the_DT opinion_NN that_IN neither_DT Psion_NNP Teklogixs_NNPS products_NNS nor_CC its_PRP$ customers_NNS use_VBP of_IN them_PRP infringes_VBZ any_DT of_IN Lemelson_NNP Medicals_NNP intellectual_JJ property_NN rights_NNS ,_, and_CC the_DT company_NN intends_VBZ to_TO defend_VB any_DT appeal_NN which_WDT may_MD be_VB brought_VBN by_IN Lemelson_NNP Medical_NNP against_IN the_DT judgement_NN of_IN the_DT District_NNP Court_NNP of_IN Nevada_NNP ._.
No_DT appeal_NN by_IN Lemelson_NNP Medical_NNP against_IN the_DT judgement_NN has_VBZ been_VBN lodged_VBN as_IN at_IN 1_CD March_NNP 2004_CD ._.
On_IN 4_CD February_NNP and_CC 5_CD February_NNP 2004_CD ,_, Lemelson_NNP Medical_NNP filed_VBD with_IN the_DT District_NNP Court_NNP of_IN Nevada_NNP two_CD motions_NNS to_TO amend_VB the_DT judgement_NN in_IN favor_NN of_IN Lemelson_NNP Medical_NNP ,_, citing_VBG inconsistencies_NNS in_IN the_DT judgement_NN ._.
Certain_NNP of_IN Psion_NNP Teklogixs_NNP customers_NNS who_WP are_VBP being_VBG sued_VBN by_IN Lemelson_NNP Medical_NNP for_IN their_PRP$ alleged_JJ infringement_NN of_IN its_PRP$ intellectual_JJ property_NN rights_NNS have_VBP ,_, in_IN the_DT past_NN ,_, sent_VBD correspondence_NN to_TO Psion_NNP Teklogix_NNP claiming_VBG indemnification_NN from_IN Psion_NNP Teklogix_NNP in_IN respect_NN of_IN any_DT sums_NNS they_PRP are_VBP required_VBN to_TO pay_VB to_TO Lemelson_NNP Medical_NNP ._.
However_RB ,_, no_DT legal_JJ action_NN has_VBZ been_VBN brought_VBN against_IN Psion_NNP Teklogix_NNP in_IN relation_NN to_TO such_JJ claims_NNS ._.
It_PRP is_VBZ not_RB possible_JJ to_TO establish_VB the_DT quantum_NN of_IN the_DT claims_NNS in_IN the_DT event_NN that_WDT legal_JJ proceedings_NNS are_VBP instigated_VBN against_IN Psion_NNP Teklogix_NNP in_IN relation_NN to_TO the_DT claims_NNS for_IN indemnity_NN ._.
Having_VBG taken_VBN legal_JJ advice_NN ,_, the_DT Board_NNP is_VBZ of_IN the_DT opinion_NN that_IN the_DT claims_NNS by_IN certain_JJ of_IN Psion_NNP Teklogixs_NNP customers_NNS for_IN indemnity_NN would_MD be_VB successfully_RB defended_VBN by_IN Psion_NNP Teklogix_NNP and_CC the_DT company_NN intends_VBZ to_TO defend_VB any_DT such_JJ actions_NNS should_MD they_PRP be_VB brought_VBN ._.
The_DT claims_NNS against_IN Psion_NNP Teklogixs_NNP customers_NNS by_IN Lemelson_NNP Medical_NNP have_VBP been_VBN stayed_VBN pending_VBG the_DT determination_NN of_IN the_DT action_NN between_IN Lemelson_NNP Medical_NNP ,_, Psion_NNP Teklogix_NNP and_CC the_DT Industry_NN Members_NNS and_CC the_DT Board_NNP has_VBZ received_VBN legal_JJ advice_NN that_IN ,_, unless_IN Lemelson_NNP Medical_NNP is_VBZ successful_JJ in_IN appealing_VBG against_IN the_DT judgement_NN of_IN the_DT District_NNP Court_NNP of_IN Nevada_NNP ,_, such_JJ claims_NNS are_VBP unlikely_JJ to_TO be_VB resumed_VBN ._.
